Colab Platforms, a small-cap integrated healthcare company, hit its 34th consecutive upper circuit at ₹69.21. The stock has surged 183% in 38 sessions. The company announced robust Q1FY26 results, with revenue up 106% year-on-year to ₹2,306.28 lakh and PAT soaring 167% to ₹120.25 lakh. An interim dividend of ₹0.01 per share was also declared.